Atmo Biosciences key facts
- Developer of a gas-sensing capsule designed to provide real-time gas information for the gut.
- It has raised $24.4M; the latest was Grant ($600K) in Apr 2025.
- Notable investors include Breakthrough Victoria, ANDHealth, State Government of Victoria, Otsuka Pharmaceutical, Alium Capital Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Atmo Biosciences: the Monday email on marks, rounds and moves
Atmo Biosciences funding rounds
No funding rounds for Atmo Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Atmo Biosciences investors
8 investors are on record for Atmo Biosciences, including Breakthrough Victoria, ANDHealth, State Government of Victoria and Otsuka Pharmaceutical.
About Atmo Biosciences
Developer of a gas-sensing capsule designed to provide real-time gas information for the gut. The company's capsule aids in reporting important data about the human gastrointestinal system by detecting gases in real-time from known locations within the gut, enabling gastroenterologists to do a preferable treatment of gastrointestinal disorders.
- Sector
- Healthcare
- HQ
- Box Hill, Australia
- Employees
- 25
- Website
- atmobiosciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Atmo Biosciences doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.